Jeff Jones

Jeff Jones

Company: Cullinan Therapeutics

Job title: Chief Medical Officer

Seminars:

Looking into the Differences in Approaching TCEs for Autoimmune vs Oncology Indications 1:00 pm

Comparing the mechanistic and translational differences in T-cell engager design for autoimmune diseases versus oncology, including target selection and immune activation thresholds Evaluating safety considerations, balancing immune activation and toxicity, and lessons learned from cytokine release syndrome management in both therapeutic areas Exploring emerging strategies to tailor T-cell engagers for autoimmune indications, including selective T-cell…Read more

day: Day 1

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.